Acute Infective Endocarditis

Infectious Disease Clinics of North America

Volumn 23, Issue 3, 2009, Pages 643-664

  McDonald, Jay R ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antimicrobial agents; Critical care; Endocarditis; Heart valves; Thoracic surgery

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFTRIAXONE; GENTAMICIN; NAFCILLIN; OXACILLIN; PENICILLIN G; RIFAMPICIN; SULTAMICILLIN; VANCOMYCIN;

ANAMNESIS; ANAPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; CATHETER INFECTION; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DEVICE REMOVAL; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; EMBOLISM; ENTEROCOCCUS; GRAM NEGATIVE BACTERIUM; HEART ABSCESS; HEART SURGERY; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE; LABORATORY TEST; LOW DRUG DOSE; MORTALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PHYSICAL EXAMINATION; PROSTHETIC VALVE ENDOCARDITIS; REVIEW; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; SURGICAL INFECTION;

ANTI-BACTERIAL AGENTS; ENDOCARDITIS, BACTERIAL; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INTENSIVE CARE UNITS;

EID: 68149173149     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2009.04.013     Document Type: Review

References (109)

1. Osler W. Gulstonian lectures on malignant endocarditis. Br Med J 1 (1885) 467-470 522-6, 577-9
2. Bashore T.M., Cabell C., and Fowler Jr. V.J. Update on infective endocarditis. Curr Probl Cardiol 4 (2006) 274-352
3. Tunkel A.R., and Scheld W.M. Experimental models of endocarditis. In: Kaye D. (Ed). Infective endocarditis (1992), Raven Press, New York 37-61
4. Wilson W., Taubert K.A., Gewitz P.B., et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 116 (2007) 1736-1754
5. Scheld W.M., Valvone J.A., and Sande M.A. Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest 61 (1978) 1394-1403
6. Burnette-Curley D., Wells V., Viscount H., et al. FimA, a major virulence determinant associated with Streptococcus parasanguis endocarditis. Infect Immun 63 (1995) 4669-4674
7. Berlin J.A., Abrutyn E., Strom B.L., et al. Incidence of infective endocarditis in the Delaware Valley, 1988-1990. Am J Cardiol 76 12 (1995) 933-936
8. Delahaye F., Goulet V., Lacassin F., et al. Characteristics of infective endocarditis in France 1991: a one year survey. Eur Heart J 16 (1995) 394-401
9. Moreillon P., and Que Y.-A. Infective endocarditis. Lancet 363 (2004) 139-149
10. Cabell C.H., Fowler Jr. V.G., Engemann J.J., et al. Endocarditis in the elderly: incidence, surgery, and survival in 16,921 patients over 12 years. Circulation 106 19 (2002) 547
11. Fowler V.G., Scheld W.M., and Bayer A.S. Endocarditis and intravascular infections. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Mandell, Douglas and Bennett's principles and practice of infectious diseases. 6th edition (2005), Churchill Livingstone, Philadelphia 975-1021
12. Durack D.T., and Petersdorf R.G. Changes in the epidemiology of endocarditis. In: Kaplan E.L., and Taranta A.V. (Eds). Infective endocarditis. An American Heart Association symposium (1977), American Heart Association, Dallas 3-23
13. Griffin M.R., Wilson W.R., Edwards W.D., et al. Infective endocarditis. Olmsted County, Minnesota, 1950 through 1981. JAMA 254 (1985) 1199-1202
14. Hoen B., Alla F., Selton-Suty C., et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288 (2002) 75-81
15. Tleyjeh I.M., Abdel-Latif A., Rahbi H., et al. A systematic review of population-based studies of infective endocarditis. Chest 132 3 (2007) 1025-1035
16. Harris S.L. Definitions and demographic characteristics. In: Kaye D. (Ed). Infective endocarditis (1992), Raven Press, New York 1-30
17. Thayer W.S. Studies on bacterial (infective) endocarditis. Johns Hopkins Hosp Rep 22 (1926) 1-8
18. Miro J.M., Anguera I., Cabell C.H., et al. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 41 (2005) 507-514
19. Selton-Suty C., Hoen B., Grentzinger A., et al. Clinical and bacteriological characteristics of infective endocarditis in the elderly. Heart 77 3 (1997) 260-263
20. McDonald J.R., Olaison L., Anderson D.J., et al. Enterococcal native valve endocarditis: report of 107 episodes from the International Collaboration on Endocarditis Merged Database. Am J Med 11 (2005) 759-766
21. Michel P.L., and Acar J. Native cardiac disease predisposing to infective endocarditis. Eur Heart J 16 Supp l B (1995) 2-9
22. Weinberger I., Rotenberg Z., Zacharovitch D., et al. Native valve infective endocarditis in the 1970s versus 1980s: underlying cardiac lesions and infecting organisms. Clin Cardiol 13 (1990) 94-98
23. Clemens J.D., Horwitz R.I., Jaffe C.C., et al. A controlled evaluation of the risk of bacterial endocarditis in persons with mitral-valve prolapse. N Engl J Med 307 (1982) 776-780
24. Gordon S.M., Serkey J.M., Longworth D.L., et al. Early onset prosthetic valve endocarditis: the Cleveland clinic experience 1992-1997. Ann Thorac Surg 69 5 (2000) 1388-1392
25. Strom B.L., Abrutyn E., Berlin J.A., et al. Risk factors for infective endocarditis: oral hygiene and nondental exposures. Circulation 102 (2000) 2842-2848
26. Pelletier L.L., and Petersdorf R.G. Infective endocarditis: a review of 125 cases from the University of Washington hospitals, 1963-72. Medicine (Baltimore) 56 (1977) 287-299
27. Martín-Dávila P., Fortún J., Navas E., et al. Nosocomial endocarditis in a tertiary hospital: an increasing trend in native valve cases. Chest 128 (2005) 772-779
28. Terpenning M.S., Buggy B.P., and Kaufmann C.A. Hospital-acquired infective endocarditis. Arch Intern Med 148 (1988) 1601-1603
29. Mourvillier B., Trouillet J.L., Timsit J.F., et al. Infective endocarditis in the intensive care unit: clinical spectrum and prognostic factors in 228 consecutive patients. Intensive Care Med 30 (2004) 2046-2052
30. Karth G.D., Koreny M., Binder T., et al. Complicated infective endocarditis necessitating ICU admission: clinical course and prognosis. Crit Care 6 (2002) 149-154
31. Gouello J.P., Asfar P., Brenet O., et al. Nosocomial endocarditis in the intensive care unit: an analysis of 22 cases. Crit Care Med 28 (2000) 377-382
32. Wolff M., Witchitz S., Chastang C., et al. Prosthetic valve endocarditis in the ICU. Prognostic factors of overall survival in a series of 122 cases and consequences for treatment decision. Chest 108 (1995) 688-694
33. Durack D.T., Lukes A.S., and Bright D.K. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke endocarditis service. Am J Med 96 (1994) 200-207
34. Bayer A.S., Ward J.L., Ginzton L.E., et al. Evaluation of new clinical criteria for the diagnosis of infective endocarditis. Am J Med 96 (1994) 211-215
35. Hoen B., Selton-Suty G., Danchin N., et al. Evaluation of the Duke criteria versus the Beth Israel criteria for the diagnosis of infective endocarditis. Clin Infect Dis 21 (1995) 905-911
36. Li J.S., Sexton D.J., Mick N., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30 (2000) 633-638
37. Sachdev M., Peterson G.E., and Jollis J.G. Imaging techniques for diagnosis of infective endocarditis. Infect Dis Clin North Am 16 (2002) 319-337
38. Kuruppu J.C., Corretti M., Mackowiak P., et al. Overuse of transthoracic echocardiography in the diagnosis of native valve endocarditis. Arch Intern Med 162 (2002) 1715-1720
39. Greaves K., Mou D., Patel A., et al. Clinical criteria and the appropriate use of transthoracic echocardiography for the exclusion of infective endocarditis. Heart 89 (2003) 273-275
40. Baddour L.M., Wilson W.R., Bayer A.S., et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications. A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council of Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association. Circulation 111 (2005) e394-e434
41. Roe M.T., Abramson M.A., Li J., et al. Clinical information determines the impact of transesophageal echocardiography on the diagnosis of infective endocarditis by the Duke criteria. Am Heart J 139 (2000) 945-951
42. Fowler V.G., Li J., Corey G.R., et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 30 (1997) 1072-1078
43. Feuchtner G.M., Stolzmann P., Dichtl W., et al. Multislice computed tomography in infective endocarditis. J Am Coll Cardiol 53 (2009) 436-444
44. Leibovici L., Vidal L., and Paul M. Aminoglycoside drugs in clinical practice: an evidence-based approach. J Antimicrob Chemother 63 (2009) 246-251
45. Falagas M.E., Matthaiou D.K., and Bliziotis I.A. The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials. J Antimicrob Chemother 57 (2006) 639-647
46. Korzeniowski O., and Sande M.A. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study. Ann Intern Med 97 (1982) 496-503
47. Vlessis A.A., Hovaguimian H., Jaggers J., et al. Infective endocarditis: Ten-year review of medical and surgical therapy. Ann Thorac Surg 61 (1996) 1217-1222
48. Wang A., Pappas P., Anstrom K.J., et al. The use and effect of surgical therapy for prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort. Am Heart J 150 (2005) 1086-1091
49. Tornos P., Iung B., Permanyer-Miralda G., et al. Infective endocarditis in Europe: lessons from the Euro-Heart Survey. Heart 91 (2005) 571-575
50. Tleyjeh I.M., Kashour T., Zimmerman V., et al. The role of valve surgery in infective endocarditis management: a systematic review of observational studies that included propensity score analysis. Am Heart J 156 (2008) 901-909
51. Vikram H.R., Buenconsejo J., Hasbun R., et al. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis. JAMA 290 (2003) 3207-3214
52. Cabell C.H., Abrutyn E., Fowler V.G., et al. Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database. Am Heart J 150 (2005) 1092-1098
53. Tleyjeh I.M., Ghomrawi H.M., Steckelberg J.M., et al. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation 115 (2007) 1721-1728
54. Sexton D.J., and Spelman D. Current best practices and guidelines: assessment and management of complications in infective endocarditis. Cardiol Clin 21 (2003) 273-282
55. Mylonakis E., and Calderwood S.B. Infective endocarditis in adults. N Engl J Med 345 (2001) 1318-1330
56. Moon M.R., Stinson E.B., and Miller D.C. Surgical treatment of endocarditis. Prog Cardiovasc Dis 40 (1997) 239-264
57. Mills J., Utley J., and Abbott J. Heart failure in infective endocarditis: predisposing factors, course, and treatment. Chest 66 (1974) 151-157
58. Graupner C., Vilacosta I., San Román J.A., et al. Periannular extension of infective endocarditis. J Am Coll Cardiol 39 (2002) 1204-1211
59. Akowuah E.F., Davies W., Oliver S., et al. Prosthetic valve endocarditis: early and late outcome following medical or surgical treatment. Heart 89 (2003) 269-272
60. Habib G., Tribouilloy C., Thuny F., et al. Prosthetic valve endocarditis: who needs surgery? A multicentre study of 104 cases. Heart 91 (2005) 954-959
61. Moss R., and Munt B. Injection drug use and right sided endocarditis. Heart 89 (2003) 577-581
62. Miro J.M., del Rio A., and Mestres C.A. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin 21 (2003) 167-184
63. Jain V., Yang M.-H., Kovacicova-Lezcano G., et al. Infective endocarditis in an urban medical center: association of individual drugs with valvular involvement. J Infect 57 (2008) 132-138
64. Hecht S., and Berger M. Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes. Ann Intern Med 117 (1992) 560-566
65. DiNubile M.J. Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users. Ann Intern Med 121 (1994) 873-876
66. Heldman A.W., Hartert T.V., Ray S.C., et al. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med 101 (1996) 68-76
67. Mahesh B., Angelini G., Caputo M., et al. Prosthetic valve endocarditis. Ann Thorac Surg 80 (2005) 1151-1158
68. Stanbridge T.N., and Isalska B.J. Aspects of prosthetic valve endocarditis. J Infect 35 (1997) 1-6
69. Piper C., Körfer R., and Horstkotte D. Prosthetic valve endocarditis. Heart 85 (2001) 590-593
70. Karchmer A.W., and Longworth D.L. Infections of intracardiac devices. Cardiol Clin 21 (2003) 253-271
71. Baddour L.M., and Wilson W.R. Prosthetic valve endocarditis and cardiovascular device-related infections. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Mandell, Douglas and Bennett's principles and practice of infectious diseases. 6th edition (2005), Churchill Livingstone, Philadelphia 1022-1044
72. Sampedro M.F., and Patel R. Infections associated with long-term prosthetic devices. Infect Dis Clin North Am 21 (2007) 785-819
73. Wang A., Athan E., Pappas P.A., et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 297 (2007) 1354-1361
74. Cabell C., Heidenreich P., Chu V., et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J 147 (2004) 582-586
75. Arber N., Pras E., Copperman Y., et al. Pacemaker endocarditis: report of 44 cases and review of the literature. Medicine 73 (1994) 299-305
76. Baddour L.M., Bettmann M.A., Bolger A.F., et al. Nonvalvular cardiovascular device-related infections. Circulation 108 (2003) 2015-2031
77. Chua J.D., Wilkoff B.L., Lee I., et al. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 133 (2000) 604-608
78. Tleyjeh I.M., Steckelberg J.M., Murad H.S., et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA 293 (2005) 3061-3062
79. Fowler V.G., Miro J.M., Hoen B., et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293 (2005) 3012-3021
80. Millar B.C., Prendergast B.D., and Moore J.E. Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis. J Antimicrob Chemother 61 (2008) 1-7
81. Cabell C.H., Jollis J.G., Peterson G.E., et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 162 (2002) 90-97
82. Chirouze C., Cabell C.H., Fowler V.G., et al. Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 38 (2004) 1323-1327
83. Chu V.H., Cabell C.H., Abrutyn E., et al. Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 39 (2004) 1527-1530
84. Anguera I., Del Rio A., Miró J.M., et al. Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles. Heart 91 (2005) e10
85. Hoen B., Chirouze C., Cabell C.H., et al. Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the International Collaboration on Endocarditis. Eur J Clin Microbiol Infect Dis 24 (2005) 12-16
86. Tripodi M.F., Adinolfi L.E., Ragone E., et al. Streptococcus bovis endocarditis and its association with chronic liver disease: an underestimated risk factor. Clin Infect Dis 38 (2004) 1394-1400
87. Anderson D.J., Olaison L., McDonald J.R., et al. Enterococcal prosthetic valve infective endocarditis: report of 45 episodes from the International Collaboration on Endocarditis Merged Database. Eur J Clin Microbiol Infect Dis 24 (2005) 665-670
88. Olaison L., and Schadewitz K. Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used?. Clin Infect Dis 34 (2002) 159-166
89. Gavalda J., Onrubia P.L., Gonez M.T., et al. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides. J Antimicrob Chemother 52 (2003) 514-517
90. Gavalda J., Len O., Miro J.M., et al. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med 146 (2007) 574-579
91. Baron E.J., Scott J.D., and Tompkins L.S. Prolonged incubation and extensive subculturing do not increase recovery of clinically significant microorganisms from standard automated blood cultures. Clin Infect Dis 41 (2005) 1677-1680
92. Morpeth S., Murdoch D., Cabell C.H., et al. Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med 147 (2007) 829-835
93. Wieland M., Lederman M.M., Kline-King C., et al. Left-sided endocarditis due to Pseudomonas aeruginosa. A report of 10 cases and review of the literature. Medicine (Baltimore) 65 (1986) 180-189
94. Levine D.P., Crane L.R., and Zervos M.J. Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study. Rev Infect Dis 8 (1986) 374-396
95. Daniel W.G., Mugge A., Martin R.P., et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med 324 (1991) 795-800
96. Anguera I., Mire J.M., Cabell C.H., et al. Clinical characteristics and outcome of aortic endocarditis with periannular abscess in the International Collaboration on Endocarditis Merged Database. Am J Cardiol 96 (2005) 976-981
97. Hill E.E., Herijgers P., Claus P., et al. Abscess in infective endocarditis: the value of transesophageal echocardiography and outcome: a 5-year study. Am Heart J 154 (2007) 923-928
98. Mouly S., Ruimy R., Launay O., et al. The changing clinical aspects of infective endocarditis: descriptive review of 90 episodes in a French teaching hospital and risk factors for death. J Infect 45 (2002) 246-256
99. Thuny F., Disalvo G., Belliard O., et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography, a prospective multicenter study. Circulation 112 (2005) 69-75
100. Heiro M., Nikoskelainen J., Engblom E., et al. Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med 160 (2000) 2781-2787
101. Steckelberg J.M., Murphy J.G., Ballard D., et al. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 114 (1991) 635-640
102. Snygg-Martin U., Gustafsson L., Rosengren L., et al. Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis 47 (2008) 23-30
103. Dickerman S.A., Abrutyn E., Barsic B., et al. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J 154 (2007) 1086-1094
104. Chu V.H., Cabell C.H., Benjamin Jr. D.K., et al. Early predictors of in-hospital death in infective endocarditis. Circulation 110 (2004) 1745-1749
105. Wallace S.M., Walton B.I., Kharbanda R.K., et al. Mortality from infective endocarditis: clinical predictors of outcome. Heart 88 (2002) 53-60
106. Leblebicioglu H., Yilmaz H., Tasova Y., et al. Characteristics and analysis of risk factors for mortality in infective endocarditis. Eur J Epidemiol 21 (2006) 25-31
107. Hsu C.N., Wang J.Y., Tseng C.D., et al. Clinical features and predictors for mortality in patients with infective endocarditis at a university hospital in Taiwan from 1995 to 2003. Epidemiol Infect 134 (2006) 589-597
108. Duval X., Alla F., Hoen B., et al. Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or without antibiotic prophylaxis. Clin Infect Dis 42 (2006) e102-e107
109. Agha Z., Lofgren R.P., and VanRuiswyk J.V. Is antibiotic prophylaxis for bacterial endocarditis cost-effective?. Med Decis Making 25 (2005) 308-320